Axcella Health Inc expected to post a loss of 30 cents a share - Earnings Preview

Axcella Health

17/03/2023 12:56

* Axcella Health Inc  AXLA.OQ   AXLA.O  is expected to show
no
change in quarterly revenue when it reports  results on March 20
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Axcella Health Inc
is for
a loss of 30 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Axcella
Health
Inc is $5​, above​ its last closing price of $0.50. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.39       -0.38      -0.34     Beat    10.9
 Jun. 30 2022  -0.39       -0.38      -0.40     Missed  -5.3
 Mar. 31 2022  -0.36       -0.39      -0.46     Missed  -17.9​
 Dec. 31 2021  -0.47       -0.45      -0.46     Missed  -2.9
 ​​Sep.        -0.45       -0.46      -0.41     Beat    10.5
 30 2021                                                
 Jun. 30 2021  -0.41       -0.43      -0.42     Beat    1.8​
 Mar. 31 2021  -0.42       -0.42      -0.40     Beat    4
 Dec. 31 2020  -0.32       -0.36      -0.40     Missed  -10.8
 This summary was machine generated March 17 at 12:56 GMT.  All
figures in US dollars  unless otherwise stated